noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

IRS - Internal Revenue Service

Use IRS Free File to conveniently file your return at no cost
Dynamic Alternatives Fund

Tender Offer Statement (Form SC TO-I)
Graybar Electric Company Inc.

Statement of Changes in Beneficial Ownership (Form 4)

Healthcare

Moleculin Biotech Inc.

01/12/2026 | Press release | Distributed by Public on 01/12/2026 07:40

Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Moleculin Biotech Inc. published this content on January 12, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 12, 2026 at 13:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]